Topics

Bristol-Myers Squibb to Announce Results for Third Quarter 2019 on October 31, 2019

06:59 EDT 12 Sep 2019 | Businesswire
Bristol-Myers Squibb Company

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the third quarter of 2019 on Thursday, October 31, 2019. During a conference call at 8:30 a.m. ET on October 31, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 800-458-4212 or international 786-789-4772, confirmation code: 532230. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 11:45 a.m. ET on October 31 through 11:45 a.m. ET on November 4, 2019. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 532230.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Bristol-Myers Squibb Company
Media:
Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com

Investors: John Elicker, 609-252-4611, john.elicker@bms.com, Tim Power 609-252-7509 timothy.power@bms.com

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb to Announce Results for Third Quarter 2019 on October 31, 2019"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...